Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ototoxic reaction to erythromycin.

C Agustí1, F Ferrán, J Gea

  • 1Department of Pneumology, Hospital Clinic, Faculty of Medicine, Barcelona, Spain.

Archives of Internal Medicine
|February 1, 1991
PubMed
Summary
This summary is machine-generated.

Intravenous erythromycin lactobionate caused bilateral hearing loss and vestibular damage in a patient, even with normal organ function and drug levels. Symptoms improved, but vestibular abnormalities suggest permanent damage from this antibiotic.

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prostaglandin E2: A Potential Link Between NSAIDs and the Menstrual Cycle, Cofactors of Food-Dependent Anaphylaxis.

Journal of investigational allergology & clinical immunology·2025
Same author

Obese Asthma Syndrome: Multiple Inflammatory Patterns and A Key Solution.

Journal of investigational allergology & clinical immunology·2025
Same author

Reduced Prostaglandin D2 Production by Airway Fibroblasts in Nonsteroidal Anti-inflammatory Drug- Exacerbated Airway Disease.

Journal of investigational allergology & clinical immunology·2025
Same author

Stability of Asthma Phenotypes in the Spanish Cohort of the MEGA Project.

Journal of investigational allergology & clinical immunology·2024
Same author

Global Lung Initiative as Diagnostic Criteria in Asthma-COPD Overlap Syndrome: Prevalence and Disease Characterization in a Real-Life Asthma Cohort.

Journal of investigational allergology & clinical immunology·2024
Same author

Reply to "Olfactory Function and Biologic Treatments: A Comment on Available Real-life Studies".

Journal of investigational allergology & clinical immunology·2023

Area of Science:

  • Otolaryngology
  • Pharmacology
  • Neurology

Background:

  • Erythromycin is a widely used antibiotic.
  • Ototoxicity is a known, though rare, side effect of some antibiotics.
  • The potential for erythromycin-induced ototoxicity requires careful monitoring.